Compare VSH & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSH | ICUI |
|---|---|---|
| Founded | 1962 | 1984 |
| Country | United States | United States |
| Employees | N/A | 13000 |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.6B |
| IPO Year | 1994 | 1995 |
| Metric | VSH | ICUI |
|---|---|---|
| Price | $35.07 | $182.98 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $18.00 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 4.8M | 318.0K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.44% | N/A |
| EPS Growth | 69.57 | ★ 100.62 |
| EPS | 0.25 | ★ 1.96 |
| Revenue | ★ $3,069,048,000.00 | $2,231,262,000.00 |
| Revenue This Year | $12.58 | N/A |
| Revenue Next Year | $6.69 | $4.46 |
| P/E Ratio | $133.30 | ★ $93.42 |
| Revenue Growth | ★ 4.48 | N/A |
| 52 Week Low | $11.77 | $112.50 |
| 52 Week High | $69.47 | $192.85 |
| Indicator | VSH | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 44.58 | 68.31 |
| Support Level | $33.36 | $138.91 |
| Resistance Level | $40.70 | $192.85 |
| Average True Range (ATR) | 2.73 | 5.07 |
| MACD | 0.49 | 0.84 |
| Stochastic Oscillator | 54.54 | 67.01 |
Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.